Table 1 Baseline characteristics according to different SHR tertiles
Variables | Total | SHR tertiles | p-value | ||
|---|---|---|---|---|---|
SHR1 (≤ 0.982) | SHR2 (0.982–1.329) | SHR3 (≥ 1.329) | |||
n | 5417 | 1809 | 1804 | 1804 | Â |
Clinical characteristics | |||||
 Age (years) | 65 (54–72) | 64 (53–71) | 65 (55–72) | 65 (56–72) |  < 0.001 |
 Female,n (%) | 1641 [30.29%] | 502 [27.75%] | 489 [27.11%] | 650 [36.03%] |  < 0.001 |
 Weight (Kg) | 65 (60–70) | 65 (60–75) | 67 (60–75) | 65 (60–75) | 0.072 |
 SBP (mmHg) | 125 (110–140) | 125 (110–140) | 128 (110–142) | 120 (105–140) |  < 0.001 |
 DBP (mmHg) | 80 (70–90) | 80 (70–90) | 80 (70–90) | 80 (69–90) | 0.006 |
 HR (beats/min) | 76 (64–88) | 76 (64–86) | 75 (64–86) | 77 (64–90) | 0.001 |
 Killip |  |  |  |  |  < 0.001 |
 1 | 4415 [81.50%] | 1522 [84.13%] | 1519 [84.20%] | 1374 [76.16%] |  |
 2 | 648 [11.96%] | 197 [10.89%] | 200 [11.09%] | 251 [13.91%] |  |
 3 | 199 [3.67%] | 56[3.10%] | 48 [2.66%] | 95 [5.27%] |  |
 4 | 155 [2.86%] | 34 [1.88%] | 37 [2.05%] | 84 [4.66%] |  |
 Angina | 442 [8.16%] | 140 [7.74%] | 152 [8.43%] | 150 [8.31%] | 0.721 |
 Anterior STE or LBBB | 2862 [52.83%] | 989 [54.67%] | 941 [52.16%] | 932 [51.66%] | 0.152 |
 Hypertension | 2177 [40.19%] | 676 [37.37%] | 727 [40.30%] | 775 [42.96%] | 0.003 |
 Diabetes mellitus | 1336 [24.66%] | 627 [34.66%] | 296 [16.41%] | 413 [22.89%] |  < 0.001 |
 Prior stroke | 520 [9.60%] | 145 [8.02%] | 172 [9.53%] | 203 [11.25%] | 0.004 |
 TIMI class |  |  |  |  |  < 0.001 |
 1 | 2415 [44.58%] | 849 [46.93%] | 863 [47.84%] | 703 [38.96%] |  |
 2 | 2113 [39.01%] | 695 [38.42%] | 691 [38.30%] | 727 [40.30%] |  |
 3 | 889 [16.41%] | 265 [14.65%] | 250 [13.86%] | 374 [20.73%] |  |
Laboratory tests | |||||
 Glucose(mmol/L) | 7.4 (6.0–9.8) | 5.7 (5.0–6.4) | 7.2 (6.5–8.2) | 11 (9.0–14.9) |  < 0.001 |
 HbA1c(%) | 5.7 (5.3–6.4) | 6.0 (5.6–6.8) | 5.6 (5.3–6.1) | 5.6 (5.2–6.3) |  < 0.001 |
 Hemoglobin(g/L) | 135 (124–148) | 136 (124–147) | 136 (124–148) | 135 (122–147) | 0.406 |
Reperfusion therapy | |||||
 Primary PCI | 691 [12.76%] | 166 [9.18%] | 251 [13.91%] | 274 [15.19%] |  < 0.001 |
 Thrombolytic therapy | 2747 [50.71%] | 880 [48.65%] | 913 [50.61%] | 954 [52.88%] | 0.039 |
Culprit lesion | 0.041 | ||||
 LAD Artery | 382 [7.05%] | 97 [5.36%] | 136 [7.54%] | 149 [8.26%] |  |
 RCA Artery | 239 [4.41%] | 50 [2.76%] | 81 [4.49%] | 108 [5.99%] |  |
 LCX Artery | 70 [1.30%] | 18 [1.00%] | 34 [1.88%] | 18 [1.00%] |  |
Medications | |||||
 Antiplatelet therapy | 5225 [96.46%] | 1730 [95.63%] | 1757 [97.39%] | 1738 [96.34%] | 0.016 |
 Statins | 3927 [72.49%] | 1338 [73.96%] | 1328 [73.61%] | 1261 [69.90%] | 0.010 |
 β-blockers | 2954 [54.53%] | 1102 [60.92%] | 1167 [64.69%] | 1087 [60.25%] | 0.013 |
 ACEI/ARB | 3874 [71.52%] | 1312 [72.53%] | 1306 [72.39%] | 1256 [69.62%] | 0.092 |
 Diuretics | 758 [13.99%] | 213 [11.77%] | 216 [11.97%] | 329 [18.24%] |  < 0.001 |